Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Evaluation of HCC Response to Systemic Therapy With Quantitative MRI
Sponsor: Icahn School of Medicine at Mount Sinai
A NA clinical study on HCC and Hepatocellular Carcinoma, this trial is completed. The trial is conducted by Icahn School of Medicine at Mount Sinai and has accumulated 10 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2020 — Aug 2020 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Mar 2019 — Feb 2020 [monthly]
Recruiting NA
-
Nov 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .